Institutt for biomedisin

Nyhetsarkiv for Institutt for biomedisin

Stroke patients have particular high risk of thrombotic events caused by platelet (thrombocyte) activation, which may lead to new infarctions. Secondary treatment of these patients with anti-platelet therapy consisting of aspirin and dipyridamole is therefore a common protocol.
Nye forskningsfunn kan bidra til mer optimalisert behandling av hjernekreft.